Acrivon Therapeutics, Inc. Common Stock (ACRV) vs LENSAR Inc (LNSR)
A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and LENSAR Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.94HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
LNSR
LENSAR Inc
$6.69HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
Total return — ACRV vs LNSR
growth of $100 · dividends reinvested · last 4yACRV -88.1% (-41.3%/yr)LNSR +53.0% (+11.2%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
ACRV LNSR
ACRV vs LNSR: by the numbers
- •ACRV is the larger company ($83M vs $82M market cap).
- •LNSR is profitable (57.57% net margin) while ACRV runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ACRV | LNSR |
|---|---|---|
| P/S ratio | N/A | 1.36 |
| P/B ratio | 0.96 | 5.51 |
Profitability
| Metric | ACRV | LNSR |
|---|---|---|
| Gross margin | 0.00% | 47.96% |
| Operating margin | 0.00% | -42.06% |
| Net margin | 0.00% | 57.57% |
| ROE | -85.65% | 232.78% |
| ROIC | -88.28% | -16.28% |
Growth (annualized)
| Metric | ACRV | LNSR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 14.67% |
| Total return CAGR (5Y) | N/A | -3.18% |
Frequently asked
- Is ACRV or LNSR more profitable?
- LNSR runs the higher net margin — ACRV at 0.00% versus LNSR at 57.57%.
Go deeper
Dig into the metrics
Acrivon Therapeutics, Inc. Common Stock ROELENSAR ROEAcrivon Therapeutics, Inc. Common Stock operating marginLENSAR operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthLENSAR revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowLENSAR free cash flow
Acrivon Therapeutics, Inc. Common Stock & LENSAR appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.